Apologies if this has already been posted...
”Receiving CE certification for EuGeni is a momentous step towards meeting an urgent global need for high-sensitivity, high-specificity rapid testing technology,” said Derek Thomson, Chief Executive Officer of AnteoTech. “As we are rapidly finalizing deals with distribution partners to facilitate large-scale rollout of our COVID-19 ART across Europe in the coming weeks, we’re continuing to refine and mature a promising selection of rapid tests in other disease areas that provide immense value – the next being an exceptionally sensitive COVID-19 saliva test.”
https://microbiozindia.com/anteotech-secures-ce-certification-for-its-versatile-eugeni-rapid-diagnostic-platform/
Ann: Test Platform and COVID-19 Test receive CE Mark approval, page-256
-
- There are more pages in this discussion • 704 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ADO (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.7¢ |
Change
0.000(0.00%) |
Mkt cap ! $67.22M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1838 | 2.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.5¢ | 2160397 | 2 |
View Market Depth
| Last trade - 16.12pm 11/11/2024 (20 minute delay) ? |
| ADO (ASX) Chart |
Day chart unavailable